Nutrition 21 subjected to FDA health claim delays
The FDA has requested an extension in its review of yet another health claims petition, for Nutrition 21's submission linking chromium picolinate with a reduced risk of insulin resistance, type 2 diabetes and related disease, writes Jess Halliday.